Close
Company Search
Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

PureTech (PRTC) Share News

12345678910

Arix Bioscience boosts net value, CEO jumping ship for PureTech Health

27th Sep 2023 10:40

(Alliance News) - Arix Bioscience PLC on Wednesday said net asset value increased in its latest half year, but has since launched a strategic review due to "unfavourable" conditions while Chief Executive Officer Robert Lyne prepares to step down. Read More

PureTech narrows interim loss despite "stormy market challenges"

29th Aug 2023 09:39

(Alliance News) - PureTech Health PLC on Tuesday said its half-year loss narrowed, but saw its revenue fall by more than half. Read More

LONDON MARKET OPEN: FTSE 100 catches up with bank holiday rally

29th Aug 2023 09:03

(Alliance News) - Stock prices in London opened higher on Tuesday, as UK markets return from a long bank holiday weekend and news that UK shop price inflation decelerated in August. Read More

LONDON BRIEFING: Bunzl profit up; Rio Tinto sells copper project stake

29th Aug 2023 07:49

(Alliance News) - Stocks in London are called to open higher on Tuesday, following a long bank holiday weekend. Read More

UK earnings, trading statements calendar - next 7 days

22nd Aug 2023 15:46

Read More

TRADING UPDATES: Plant Health in Poland boost; PureTech gets US grant

1st Aug 2023 17:31

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More

PureTech Health launches next stage of anxiety disorder drug trial

21st Jun 2023 12:36

(Alliance News) - PureTech Health PLC on Wednesday said that it has started the next stage of trials for LYT-300, in order to test whether the therapy could be used to treat anxiety disorders. Read More

PureTech Health's Akili launches ADHD immersive treatment in US

7th Jun 2023 13:57

(Alliance News) - PureTech Health PLC on Wednesday said its founded entity, Akili Inc, released an attention deficit hyperactivity disorder treatment for adult patients. Read More

PureTech's Vedanta Biosciences receives US FDA fast track designation

9th May 2023 11:13

(Alliance News) - PureTech Health PLC on Tuesday said its founded entity, Vedanta Biosciences, has been granted fast track designation from the US Food & Drug Administration for its bacterial consortium candidate, VE303, for the prevention of recurrent Clostridioides difficile infection. Read More

IN BRIEF: PureTech notes Akili's results for EndeavorRx ADHD trial

4th May 2023 11:46

PureTech Health PLC - Boston-based biotechnology company - Says its founded entity, Akili, announced clinical trial for video game-based therapy, EndeavorRx, showed improvement in attention and quality of life for people with attention deficit hyperactivity disorder. Notes attention improved in more than 80% of adults with ADHD, while over a third of participants "no longer exhibited an attention deficit following treatment." Read More

LONDON BROKER RATINGS: HSBC raises Rightmove to 'buy' from 'hold'

2nd May 2023 09:34

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning: Read More

PureTech Health yearly loss widens but remains optimistic

28th Apr 2023 11:13

(Alliance News) - PureTech Health PLC on Friday said its loss widened in 2022 and revenue declined, though it hailed an "exceptional" year and expects further success in 2023. Read More

TRADING UPDATES: Eagle Eye signs new John Lewis deal, Neometals update

25th Apr 2023 18:33

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on xxxday and not separately reported by Alliance News: Read More

UK earnings, trading statements calendar - next 7 days

21st Apr 2023 15:51

Read More

PureTech Health's Vedanta Biosciences boasts "promising" results

17th Apr 2023 09:01

(Alliance News) - PureTech Health PLC on Monday said that its founded entity, Vedanta Biosciences, has seen positive results for its lead programme, VE303. Read More

LONDON MARKET MIDDAY: Bank of England lifts rates by 25 basis points

23rd Mar 2023 12:23

(Alliance News) - Stock prices in London were largely lower at midday on Thursday, raised UK interest rates by 25 basis points on Thursday, as widely expected, and indicated that further tightening in monetary policy may be required. Read More

PureTech Health says Royalty Pharma acquires Karuna Royalties

23rd Mar 2023 10:11

(Alliance News) - PureTech Health PLC on Thursday said Royalty Pharma PLC has acquired an interest in PureTech's royalty in Karuna Therapeutics Inc's KarXT schizophrenia treatment. Read More

PureTech Health says Karuna KArXT trial receives positive results

20th Mar 2023 16:01

(Alliance News) - PureTech Health PLC on Monday said its founded entity, Karuna Therapeutics Inc announced its phase 3 EMERGENT-3 trial of KarXT in Schizophrenia has met its primary endpoint. Read More

TRADING UPDATES: Eco Atlantic swings to loss; Curtis approves takeover

28th Feb 2023 21:05

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News: Read More

IN BRIEF: PureTech Health to start trials for anxiety, depression drug

14th Feb 2023 13:27

PureTech Health PLC - clinical-stage biotherapeutics company - Says it will advance LYT-300 for the potential treatment of anxiety disorders and post-partum depression. A placebo-controlled, phase 2a, proof-of-concept, social anxiety clinical trial is expected to begin in the first half of 2023. Results are expected by the end of the year. An open-label, phase 2a, proof-of-concept clinical trial in women with post-partum depression is expected to begin in the second half of 2023. Read More

12345678910
FTSE 100 Latest
Value8,809.74
Change53.53